Evidence supporting the use of: Bifidobacterium bifidum
For the health condition: Diverticulitis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Bifidobacterium bifidum is one of several probiotic bacteria that have been studied in relation to gastrointestinal health, including conditions like diverticulitis. The use of B. bifidum for diverticulitis is primarily based on scientific rationale and emerging evidence, though the data are still limited and not definitive.

Diverticulitis is an inflammatory condition of the colon that follows the development of diverticula (small pouches) in the intestinal wall. Disruption of the gut microbiota (dysbiosis) is thought to play a role in both diverticulosis and diverticulitis. Probiotics, including B. bifidum, may help restore a healthy balance of bacteria, reduce inflammation, and support the intestinal barrier.

Several small clinical studies and reviews have evaluated the role of probiotics in preventing recurrence of diverticulitis or alleviating symptoms of diverticular disease. Some multi-strain probiotic formulations that include B. bifidum have been associated with reduced symptoms (such as bloating and discomfort) and lower recurrence rates of diverticulitis, especially when combined with high-fiber diets. However, most studies do not isolate the effect of B. bifidum alone, and the evidence is not robust enough for strong clinical recommendations. Major guidelines still call for more high-quality, large-scale clinical trials.

In summary, while there is a plausible scientific basis and some early evidence supporting the use of B. bifidum as part of probiotic therapy for diverticulitis, the overall quality and quantity of evidence is limited (rated 2/5). Probiotic use should always be discussed with a healthcare provider.

More about bifidobacterium bifidum
More about Diverticulitis